Camila Guajardo-Flores, Josefa Rojas, Yvan Baldera-Moreno, Francisco Adasme-Carreño, Daisuke Kasai, Rodrigo Andler
{"title":"通过酶动力学和工艺改进对聚顺-1,4-异戊二烯橡胶降解的新认识。","authors":"Camila Guajardo-Flores, Josefa Rojas, Yvan Baldera-Moreno, Francisco Adasme-Carreño, Daisuke Kasai, Rodrigo Andler","doi":"10.3389/fbioe.2025.1593339","DOIUrl":null,"url":null,"abstract":"<p><p>Latex clearing protein (Lcp) is a crucial enzyme in the oxidative degradation of poly(<i>cis</i>-1,4-isoprene), the main component of natural rubber (NR). Despite significant biochemical advances, to date, the kinetic behavior of Lcp from <i>Streptomyces</i> sp. K30 (Lcp<sub>K30</sub>) has not been characterized, limiting the efficiency of NR conversion. In this work, Lcp<sub>K30</sub> was produced in <i>Escherichia coli</i> BL21 (DE3) + p4782.1::<i>lcp</i> <sub>K30</sub> with L-rhamnose as the inducer, yielding 6.05 mg/L of purified protein. Kinetic assays demonstrated a positive correlation between the initial reaction rate and poly(<i>cis</i>-1,4-isoprene) concentration, reaching a maximum rate of 7.05 nmol O<sub>2</sub>/min at the enzyme's saturation point, corresponding to 5 μg Lcp/mg NR. The Michaelis-Menten constant (K<sub>m</sub>) was determined to be 308.3 mg/mL, with the Hill model providing the best fit for the data. NR-to-oligoisoprenoid conversion reached 12.9 mg in 24 h, exceeding previously reported yields, while gel permeation chromatography analysis indicated conversion efficiencies over 80%, far exceeding the reports of previous studies where only 30%-40% conversions were achieved. Furthermore, Fukui function analysis suggested that the aldehyde terminal groups of the oligoisoprenoids may be less susceptible to enzymatic degradation, which would explain the mass distribution of the degradation products.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1593339"},"PeriodicalIF":4.3000,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12081455/pdf/","citationCount":"0","resultStr":"{\"title\":\"New insights on poly(<i>cis</i>-1,4-isoprene) rubber degradation through enzymatic kinetics and process improvement.\",\"authors\":\"Camila Guajardo-Flores, Josefa Rojas, Yvan Baldera-Moreno, Francisco Adasme-Carreño, Daisuke Kasai, Rodrigo Andler\",\"doi\":\"10.3389/fbioe.2025.1593339\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Latex clearing protein (Lcp) is a crucial enzyme in the oxidative degradation of poly(<i>cis</i>-1,4-isoprene), the main component of natural rubber (NR). Despite significant biochemical advances, to date, the kinetic behavior of Lcp from <i>Streptomyces</i> sp. K30 (Lcp<sub>K30</sub>) has not been characterized, limiting the efficiency of NR conversion. In this work, Lcp<sub>K30</sub> was produced in <i>Escherichia coli</i> BL21 (DE3) + p4782.1::<i>lcp</i> <sub>K30</sub> with L-rhamnose as the inducer, yielding 6.05 mg/L of purified protein. Kinetic assays demonstrated a positive correlation between the initial reaction rate and poly(<i>cis</i>-1,4-isoprene) concentration, reaching a maximum rate of 7.05 nmol O<sub>2</sub>/min at the enzyme's saturation point, corresponding to 5 μg Lcp/mg NR. The Michaelis-Menten constant (K<sub>m</sub>) was determined to be 308.3 mg/mL, with the Hill model providing the best fit for the data. NR-to-oligoisoprenoid conversion reached 12.9 mg in 24 h, exceeding previously reported yields, while gel permeation chromatography analysis indicated conversion efficiencies over 80%, far exceeding the reports of previous studies where only 30%-40% conversions were achieved. Furthermore, Fukui function analysis suggested that the aldehyde terminal groups of the oligoisoprenoids may be less susceptible to enzymatic degradation, which would explain the mass distribution of the degradation products.</p>\",\"PeriodicalId\":12444,\"journal\":{\"name\":\"Frontiers in Bioengineering and Biotechnology\",\"volume\":\"13 \",\"pages\":\"1593339\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-05-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12081455/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Bioengineering and Biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.3389/fbioe.2025.1593339\",\"RegionNum\":3,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1593339","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
New insights on poly(cis-1,4-isoprene) rubber degradation through enzymatic kinetics and process improvement.
Latex clearing protein (Lcp) is a crucial enzyme in the oxidative degradation of poly(cis-1,4-isoprene), the main component of natural rubber (NR). Despite significant biochemical advances, to date, the kinetic behavior of Lcp from Streptomyces sp. K30 (LcpK30) has not been characterized, limiting the efficiency of NR conversion. In this work, LcpK30 was produced in Escherichia coli BL21 (DE3) + p4782.1::lcpK30 with L-rhamnose as the inducer, yielding 6.05 mg/L of purified protein. Kinetic assays demonstrated a positive correlation between the initial reaction rate and poly(cis-1,4-isoprene) concentration, reaching a maximum rate of 7.05 nmol O2/min at the enzyme's saturation point, corresponding to 5 μg Lcp/mg NR. The Michaelis-Menten constant (Km) was determined to be 308.3 mg/mL, with the Hill model providing the best fit for the data. NR-to-oligoisoprenoid conversion reached 12.9 mg in 24 h, exceeding previously reported yields, while gel permeation chromatography analysis indicated conversion efficiencies over 80%, far exceeding the reports of previous studies where only 30%-40% conversions were achieved. Furthermore, Fukui function analysis suggested that the aldehyde terminal groups of the oligoisoprenoids may be less susceptible to enzymatic degradation, which would explain the mass distribution of the degradation products.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.